RESISTANT HYPERTENSION
Clinical trials for RESISTANT HYPERTENSION explained in plain language.
Never miss a new study
Get alerted when new RESISTANT HYPERTENSION trials appear
Sign up with your email to follow new studies for RESISTANT HYPERTENSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill could tame stubborn high blood pressure
Disease control CompletedThis Phase 3 trial tested a new drug called lorundrostat in over 1,000 adults whose high blood pressure remained uncontrolled despite taking 2 to 5 other medications. Participants received either lorundrostat or a placebo daily for 12 weeks. The main goal was to see if the drug l…
Matched conditions: RESISTANT HYPERTENSION
Phase: PHASE3 • Sponsor: Mineralys Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New pill may help when blood pressure meds aren't enough
Disease control CompletedThis study tested a new drug called baxdrostat in 326 adults whose high blood pressure was not controlled even with two or more medications. Participants took either 1 mg, 2 mg of baxdrostat, or a placebo daily for 12 weeks. The main goal was to see if baxdrostat could lower syst…
Matched conditions: RESISTANT HYPERTENSION
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New drug aimed at stubborn high blood pressure passes final trial phase
Disease control CompletedThis Phase 3 trial tested a once-daily pill called baxdrostat in 218 adults with resistant hypertension—high blood pressure that stays high despite taking three or more medications. Participants received either baxdrostat or a placebo for 12 weeks. The main goal was to see if bax…
Matched conditions: RESISTANT HYPERTENSION
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New shot could tame stubborn high blood pressure
Disease control CompletedThis study tested a new drug called XXB750 in 189 people with resistant hypertension—high blood pressure that doesn't get better with standard treatments. Participants received either a placebo or one of several doses of XXB750 as a shot under the skin, on top of their usual medi…
Matched conditions: RESISTANT HYPERTENSION
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New drug baxdrostat aims to tame stubborn high blood pressure
Disease control CompletedThis Phase 3 trial tested a daily pill called baxdrostat in about 800 adults whose blood pressure stays high even when taking two or more other medications. Participants received either 1 mg, 2 mg, or a placebo for 12 weeks. The main goal was to see if baxdrostat could safely low…
Matched conditions: RESISTANT HYPERTENSION
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Talking to a nurse may ease blood pressure pill side effects
Symptom relief CompletedThis study tested whether one-on-one sessions with a trained nurse could help people with resistant hypertension better handle side effects like sexual problems and bladder control issues caused by their blood pressure medications. The goal was to see if this education helps pati…
Matched conditions: RESISTANT HYPERTENSION
Phase: NA • Sponsor: Consorci Sanitari Integral • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
Skin blood flow test may predict heart danger in tough-to-treat high blood pressure
Knowledge-focused CompletedThis completed study looked at 111 people to see if measuring blood flow in the skin can help assess cardiovascular risk in those with resistant hypertension (high blood pressure that doesn't respond to multiple drugs). Researchers used a laser device to check how well tiny blood…
Matched conditions: RESISTANT HYPERTENSION
Sponsor: National Institute of Cardiology, Laranjeiras, Brazil • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Hidden hormone link in stubborn high blood pressure revealed
Knowledge-focused CompletedThis study looked at over 1,100 adults in the US whose high blood pressure stays high despite taking multiple medications. Researchers checked if these people also have a hormone condition called endogenous hypercortisolism, where the body makes too much cortisol. Participants ga…
Matched conditions: RESISTANT HYPERTENSION
Sponsor: Corcept Therapeutics • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC